Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain

Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain

Veure altres versions (1)

Dades bibliogràfiques
Autors principals:	Serres, S, Anthony, D, Jiang, Y, Campbell, S, Merkler, D, Bruck, W, Recton, J, Sibson, N
Format:	Conference item
Publicat:	2009

Ítems similars

CONTRIBUTION OF PERIPHERAL IL-1BETA EXPRESSION IN THE SYSTEMIC REACTIVATION OF FOCAL MOG-EAE LESIONS IN RAT BRAIN
per: Serres, S, et al.
Publicat: (2009)

Reactivation of a focal EAE lesion by a systemic inflammatory response
per: Serres, S, et al.
Publicat: (2007)

EAE Induction by Passive Transfer of MOG-specific CD4+ T Cells
per: Yuki Tanaka, et al.
Publicat: (2017-07-01)

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis
per: Serres, S, et al.
Publicat: (2013)

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
per: Serres, S, et al.
Publicat: (2013)

ANTI-IL17 TREATMENT REDUCES CLINICAL SCORE AND VCAM-1 EXPRESSION IN EAE-ABH MICE DETECTED BY IN VIVO MAGNETIC RESONANCE IMAGING
per: Serres, S, et al.
Publicat: (2009)

Systemic inflammatory response reactivates immune-mediated lesions in rat brain.
per: Serres, S, et al.
Publicat: (2009)

Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.
per: Mardiguian, S, et al.
Publicat: (2013)

Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE.
per: Campbell, S, et al.
Publicat: (2010)

Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
per: Madrigal José LM, et al.
Publicat: (2010-10-01)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
per: Kwon, Y, et al.
Publicat: (2019)

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation
per: S. K. Vainio, et al.
Publicat: (2022-02-01)

Peripheral nervous system involvement in MOG antibody-associated demyelination
per: Ramanathan, S, et al.
Publicat: (2019)

Peripheral nervous system manifestations of MOG antibody associated disease
per: Pranjal Gupta, et al.
Publicat: (2024-04-01)

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
per: Ericsson-Dahlstrand Anders, et al.
Publicat: (2007-05-01)

Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
per: Wolfensohn, S, et al.
Publicat: (2013)

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders
per: Rinaldi, S, et al.
Publicat: (2020)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
per: Martin S. Weber, et al.
Publicat: (2018-03-01)

Profiling the microRNA signature of the peripheral sensory ganglia in experimental autoimmune encephalomyelitis (EAE)
per: Timothy N. Friedman, et al.
Publicat: (2019-11-01)

Proton MR spectroscopy in characterization of focal bone lesions of peripheral skeleton
per: Meenu Amar, et al.
Publicat: (2019-12-01)

An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE
per: Joshua S. Stoolman, et al.
Publicat: (2018-07-01)

Autoimmunity to astrocytes in multiple sclerosis and EAE
per: Amor, S, et al.
Publicat: (2011)

Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration
per: Zhe Ji, et al.
Publicat: (2019-08-01)

Expression of IL-20 Receptor Subunit β Is Linked to EAE Neuropathology and CNS Neuroinflammation
per: Jacquelyn R. Dayton, et al.
Publicat: (2021-09-01)

Anti-MOG associated myelitis
per: A. I. Isaykin, et al.
Publicat: (2020-06-01)

Moffat MOdified Gravity (MOG)
per: Sreekanth Harikumar
Publicat: (2022-04-01)

Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production
per: Sofia Fernanda Gonçalves Zorzella-Pezavento, et al.
Publicat: (2013-01-01)

Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
per: Hilary A. Seifert, et al.
Publicat: (2019-10-01)

An approach to segmentation of a solid focal lesion in breast and its peripheral areas in ultrasound images
per: D.V. Pasynkov, et al.
Publicat: (2023-06-01)

Characteristics of TSPO expression in marmoset EAE
per: Irene Falk, et al.
Publicat: (2025-01-01)

Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE
per: Marija Jakovljevic, et al.
Publicat: (2019-04-01)

Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MS
per: Jifang Gao, et al.
Publicat: (2017-04-01)

MOG-IgG1 antibodies in children
per: Waters, P, et al.
Publicat: (2018)

ASIC1 expression contributes to demyelination and axonal injury in EAE and MS
per: Vergo, S, et al.
Publicat: (2009)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease (Proceeding of the National Academy of Sciences of the United States of America (2009) 106, 1, (18-23) doi: 10.1073/pnas.0806787106)
per: Van Kasteren, S, et al.
Publicat: (2009)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease.
per: van Kasteren, S, et al.
Publicat: (2009)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease (vol 106, pg 18, 2008)
per: van Kasteren, S, et al.
Publicat: (2009)

EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses
per: Ralf A. Linker, et al.
Publicat: (2005-06-01)

Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE
per: Ameneh Ghaffarinia, et al.
Publicat: (2016-04-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
per: Jurynczyk, M, et al.
Publicat: (2017)